TY - JOUR T1 - The OMERACT MRI Inflammatory Arthritis Group: Advances and Future Research Priorities JF - The Journal of Rheumatology JO - J Rheumatol SP - 1803 LP - 1805 DO - 10.3899/jrheum.090349 VL - 36 IS - 8 AU - PHILIP G. CONAGHAN AU - PAUL BIRD AU - FIONA McQUEEN AU - CHARLES PETERFY AU - PERNILLE BØYESEN AU - FRÉDÉRIQUE GANDJBAKHCH AU - ANNE DUER-JENSEN AU - ESPEN A. HAAVARDSHOLM AU - BO EJBJERG AU - CHARLOTTE WIELL AU - LAURA COATES AU - KAY-GEERT A. HERMANN AU - PHILIP O’CONNOR AU - MARISSA LASSERE AU - JANE E. FREESTON AU - ALLEN ANANDARAJAH AU - HARRY GENANT AU - PAUL EMERY AU - MIKKEL ØSTERGAARD Y1 - 2009/08/01 UR - http://www.jrheum.org/content/36/8/1803.abstract N2 - The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group’s effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS. ER -